We are live on ! Find out more
LDRS

Innovator IBD ETF Leaders ETF

Delisted

LDRS was delisted on the 13th of August, 2021.

4 hedge funds and large institutions have $531K invested in Innovator IBD ETF Leaders ETF in 2020 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% less funds holding

Funds holding: 84 (-4)

70% less capital invested

Capital invested by funds: $1.75M → $531K (-$1.22M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 4

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 3

Holders
4
Holders Change
-4
Holders Change %
-50%
% of All Funds
0.08%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
3
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Citadel Advisors
1
Citadel Advisors
Florida
$388K -$30.3K -1,587 -8%
UBS Group
2
UBS Group
Switzerland
$64K -$57 -3 -0.1%
Osaic Holdings
3
Osaic Holdings
Arizona
$59K -$19.4K -1,017 -26%
Royal Bank of Canada
4
Royal Bank of Canada
Ontario, Canada
$20K
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
-$777K -41,749 Closed
Jane Street
6
Jane Street
New York
-$211K -11,358 Closed
LPL Financial
7
LPL Financial
California
-$187K -10,057 Closed
ASN
8
Advisory Services Network
Georgia
-$37K -2,000 Closed

LDRS Hedge Fund Activity: Q2 2020 in Review

4 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Innovator IBD ETF Leaders ETF (LDRS) for Q2 2020, worth a combined $531K — down 70% from $1.75M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of LDRS and 0 opened new positions — a net loss of 4 holders — while 3 trimmed existing stakes and 0 added.

The largest seller was Susquehanna International Group, exiting entirely with an estimated $777K sold.

  • 4 institutional investors held Innovator IBD ETF Leaders ETF (LDRS) as of Q2 2020, down from 8 in Q1 2020.
  • Funds reported $531K of Innovator IBD ETF Leaders ETF stock for Q2 2020, down 70% quarter-over-quarter.
  • 0 funds opened new Innovator IBD ETF Leaders ETF positions in Q2 2020 and 4 closed out, a net change of -4 holders.
  • The largest Innovator IBD ETF Leaders ETF seller in Q2 2020 was Susquehanna International Group, an estimated $777K sold.

Based on aggregated 13F filings for Q2 2020.